Biotechnology refers to that of a science which is majorly related to the uses of living beings, organic systems, or by-products to modify or advance procedures and outcomes for the expansion of healthcare goods and drugs. Also, it has been observed that the biotechnology heavily impacts variety of businesses such as drug and pharmaceuticals, nutrition and chemical market, and many more.
According to the report analysis, ‘Biotechnology Market: Current Analysis and Forecast (2021-2027)’ states that some of the major players operating in the market include Abbott Laboratories, Amgen, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen, Thermo Fisher Scientific, etc. Several M&A’s which have been covered in the report at the various level with multiple cross comparisons and product and services offered along with partnerships which have been commenced by these players to enhance their existence in different regions.
Moreover, report includes an in-depth analysis about the market which has been further segmented majorly on the basis of technology and application. Therefore, the biotechnology market has been further categorised by Technology (Nano biotechnology, tissue engineering & regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others), and by Application (bio-pharmacy, bio-services, bio-agriculture, bio-industrial, and bioinformatics).
On the other hand, market adoption of the Biotechnology market has also been analysed based on its worldwide penetration in the countries such as North America (United States, Canada, and Other region of North Amercia), Europe (France, Germany, United Kingdom Italy, Spain, and Other regions of Europe), Asia-Pacific (China, India, Australia, Japan, and other regions of APAC), and other part of the World. North America constituted a major market for the Biotechnology industry and generated significant revenue of USD billion in 2020 owing to the presence of major players, wide-ranging R&D activities, and high healthcare expenditure, and many more. However, it is anticipated that the in the near future the Asia Pacific region will grow at the highest rate during the forecast period of 2021 – 2027.
In addition to this, the growth of the biotechnology sector in developing countries such as India and China have been largely driven by favourable government initiatives. Government activities are intended at revolutionizing the medicines supervisory system, regulating clinical trials, attractive reimbursement rules, and accelerating the product sanction process, all of which promise eye-catching development potential. Moreover, agricultural companies are concentrating their efforts on bringing agricultural innovations in the market to boost production through long-term solutions. For instance, BASF said by 2029, they will launch more than 30 initiatives aimed at producing novel seeds, traits, biological and chemical crop protection solutions, new formulations, and digital products. However, it has been also observed that the risks which are being associated with the genetic conditions can negatively impact the market to grow.
In the near future, report also forecasts that the biotechnology market will increase at a significant CAGR during the period 2021 – 2027 majorly due to the continuous advancements and wide range of applications coupled with the growing demand for food with increasing population and rising adoption of Genetically Modified (GM) crops is likely to fuel the bio-agriculture segment.
For More Information, refer to below link:-
Follow Us:-
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
